Technologies invented and patented by researchers at the Frederick National Laboratory for Cancer Research are on...
Research led by the Frederick National Laboratory for Cancer Research (FNL) and Gilead Sciences shows the potential for...
After three years of COVID-19, science has learned much about the disease and the virus that causes it, SARS-CoV-2. But...

All News

[Apply]
Category
Date Posted Range
Limit results to Case Studies

Conference to celebrate and support Black cancer researchers 

Posted 2/21/2024
The cancer community will come together for a two-day conference designed to celebrate Black contributions in cancer research and to connect future investigators and collaborators, in order to pave the way for the next generation of Black cancer research professionals.  Black in Cancer, a US/UK-based organization and the Frederick National Laboratory for Cancer Research…

Mickey Williams’ lifelong love for science enters emeritus era

Molecular Characterization LaboratoryPosted 2/15/2024
Mickey Williams, Ph.D., jokes that he was “somewhat doomed to become a molecular biologist” from the very start, born within mere hours of a milestone in the field. The same day in 1953 that Francis Crick and James Watson heralded their discovery of DNA’s double-helix structure — “the secret of life,” Crick triumphantly called it at The Eagle pub in Cambridge—Williams…

Specific retinoid shrinks immune checkpoint-resistant lung cancers in mice

Posted 2/7/2024
Frederick National Laboratory researchers identified a vitamin A derivative (retinoid) that when combined with a standard immunotherapy will shrink otherwise checkpoint-resistant lung tumors in mice, a potential step toward human clinical trials to improve lung cancer treatment. The research, described in Scientific Reports, focused on all-trans-retinoic acid (ATRA), a…

Patent display highlights innovation by Frederick National Laboratory researchers

Partnership Development OfficePosted 1/25/2024
Technologies invented and patented by researchers at the Frederick National Laboratory for Cancer Research are on display at the laboratory’s Advanced Technology Research Facility to highlight the innovation that is integral to FNL’s mission to discover and innovate to improve human health. “Securing a patent is a huge accomplishment in general and a major accomplishment…

Biotech Connector highlights marvels in mass spectrometry

Partnership Development OfficePosted 1/18/2024
Frederick-area biotechnology professionals got an inside look at advances in mass spectrometry as part of the quarterly Biotech Connector Series at the Frederick National Laboratory for Cancer Research. Mass spectrometry is an analytical technique that allows scientists to determine the mass, structure, and chemical properties of molecules. It is a powerful tool with…

New drug to treat HIV might also be used to block infection altogether

AIDS and Cancer Virus Program, Viral Persistence SectionPosted 1/9/2024
Research led by the Frederick National Laboratory for Cancer Research (FNL) and Gilead Sciences shows the potential for a new drug that might only need to be taken twice a year to prevent HIV infection. The drug manufacturer is planning a clinical trial.  The drug, Lenacapavir, recently approved by the Food and Drug Administration as a treatment for multi-drug resistant…

Morehouse School of Medicine biospecimens to boost diversity of cancer samples for proteogenomic analysis

Partnership Development OfficePosted 10/11/2023
A national effort to understand the molecular basis of numerous cancers by analyzing proteins and genes will benefit from greater diversity in patient samples through a new agreement with the Morehouse School of Medicine, a historically Black medical school in Atlanta. MSM joins the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC)…

AI enhances method for rapid diagnosis, potentially better treatment of endometrial cancer

Posted 10/9/2023
Artificial intelligence has helped researchers uncover potential avenues for better treatment of endometrial cancer, the most common gynecologic malignancy in the developed world and one with a worsening mortality rate, particularly among Blacks and Hispanics. With the aid of deep learning, a type of AI, a large multi-institutional collaboration including the Frederick…

ATOM summer training program builds student skill sets and opens doors for career opportunities

Cancer Data Science InitiativesPosted 10/3/2023
Three students from Butler University and Hood College participated in a 10-week virtual training at the Frederick National Laboratory for Cancer Research, learning more about tools developed by the Accelerated Therapeutics for Opportunities in Medicine (ATOM). FNL co-founded the ATOM consortium in 2017 as a public–private collaboration with universities, other national…

2023 Technology Showcase Highlights How Partnerships Move the Science Forward

Center for Innovation and Strategic Partnerships, Partnership Development OfficePosted 9/28/2023
With 100 online attendees, 180 in-person participants, 15 posters, 16 technologies, and 45 speakers, the 2023 Technology Showcase offered a whirlwind look into the biotechnology innovation happening at the Frederick National Laboratory and National Cancer Institute. “This is a valuable event to make connections and show potential partners what we can do,” said Maggie…